Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy

Recruiting now · Not applicable

Conditions studied: ILD, COPD

In brief

Assess quality of life of patients using prolonged oxygen therapy

Key facts

Study ID

NCT06882265

Run by

University of Sao Paulo General Hospital

People needed

60

Starts

2024-11-10

Expected to finish

2025-12-15

Last updated by the study team

2025-03-18

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a clinical, radiological and/or anatomopathological diagnosis of COPD and ILD according to the 2020 ATS/JRS/ALAT guidelines;
• Age over 18 years;
• Clinical stability (absence of exacerbations or hospitalizations related to the underlying disease) for at least 6 weeks;
• Patients who are on optimized drug therapy, including long-term home oxygen therapy (LTOT)
• Have a smartphone compatible with the monitoring device;
• Signing of the ICF to participate in the study.

You may not qualify if…

• Presence of other concomitant lung diseases;
• Myocardial infarction within four months prior to the start of the study, unstable angina or severe heart disease (NYHA functional class III-IV) and/or decompensated.
• Patients who received a lung transplant during the study
• Living outside the coverage area or moving out of state

Where it is running

• Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), — São Paulo, São Paulo, Brazil (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.